All VA diagnostic codes › §4.124a
38 CFR Diagnostic Code 8540 — Soft-tissue sarcoma (of neurogenic origin)
Rating schedule §4.124a — § 4.124a Schedule of ratings—neurological conditions and convulsive disorders.
| Rating | Criteria (38 CFR §4.124a) |
|---|---|
| 100% | Soft-tissue sarcoma (of neurogenic origin) |
| A thorough study of all material in §§ 4.121 and 4.122 of the preface and under the ratings for epilepsy is necessary prior to any rating action. | |
Notes in the regulation
- Note: The 100 percent rating will be continued for 6 months following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. At this point, if there has been no local recurrence or metastases, the rating will be made on residuals.
Source. Quoted from 38 CFR Part 4, the VA Schedule for Rating Disabilities, as published by the eCFR for 2026-07-01. We quote the regulation rather than paraphrase it. The rating schedule changes; check the eCFR link for the current text.
Official 2026 VA monthly compensation, including the 2.8% COLA increase.
Dependent add-ons start at a 30% rating. Child-only and dependent-parent rates: see the full 2026 pay chart.
2026 base rates, all ratings (veteran alone)
| Rating | Monthly (2026, incl. 2.8% COLA) |
|---|---|
| 10% | $180.42 |
| 20% | $356.66 |
| 30% | $552.47 |
| 40% | $795.84 |
| 50% | $1,132.90 |
| 60% | $1,435.02 |
| 70% | $1,808.45 |
| 80% | $2,102.15 |
| 90% | $2,362.30 |
| 100% | $3,938.58 |
This is reference information, not a rating decision and not legal advice. What a claim actually receives depends on the evidence of record.
Does your rating decision hold up under a real audit?
Upload your decision letter and C&P exams — VetAid's analyzer reads the full file, checks every examiner statement word-for-word against your records, and shows which arguments for a higher rating actually hold. Free, and we never take a cut of your back pay.
Analyze my claim free →